{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:33:42Z","timestamp":1784691222692,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research: Neuroimaging"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.pscychresns.2007.04.006","type":"journal-article","created":{"date-parts":[[2008,1,17]],"date-time":"2008-01-17T08:03:20Z","timestamp":1200557000000},"page":"159-166","source":"Crossref","is-referenced-by-count":26,"title":["[99mTc]TRODAT-1\/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome"],"prefix":"10.1016","volume":"162","author":[{"given":"Wen-Juh","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Kai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Shoei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pscychresns.2007.04.006_bib1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.WNL.0000076181.39162.FC","article-title":"Increased ventral striatal monoaminergic innervation in Tourette syndrome","volume":"61","author":"Albin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","first-page":"101","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib3","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1212\/01.WNL.0000123111.00324.BF","article-title":"Ropinirole in Gilles de la Tourette syndrome","volume":"62","author":"Anca","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib4","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1531-8257(200011)15:6<1194::AID-MDS1019>3.0.CO;2-H","article-title":"Response to levodopa challenge in Tourette syndrome","volume":"15","author":"Black","year":"2000","journal-title":"Movement Disorders"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib5","first-page":"227","article-title":"PET studies on the integrity of the pre- and post-synaptic dopaminergic system in Tourette syndrome","volume":"58","author":"Brooks","year":"1992","journal-title":"Advances in Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4088\/JCP.v62n0111","article-title":"Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study","volume":"62","author":"Bruggeman","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ana.410060109","article-title":"Biogenic amine metabolism in Tourette syndrome","volume":"6","author":"Butler","year":"1979","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0306-4522(89)90179-6","article-title":"Dopamine receptors in human brain: autoradiographic distribution of D2 sites","volume":"28","author":"Camps","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1109\/TNS.1978.4329385","article-title":"A method for attenuation correction in radionuclide computed tomography","volume":"NS25","author":"Chang","year":"1978","journal-title":"IEEE Transactions on Nuclear Science"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pscychresns.2003.06.001","article-title":"Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-na\u00efve children with Tourette's disorder","volume":"130","author":"Cheon","year":"2004","journal-title":"Psychiatry Research. Neuroimaging"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/archpsyc.1978.01770260123015","article-title":"Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration","volume":"35","author":"Cohen","year":"1978","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004714-200202000-00006","article-title":"Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial","volume":"22","author":"Dion","year":"2002","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004583-199901000-00024","article-title":"High presynaptic dopaminergic activity in children with Tourette's disorder","volume":"38","author":"Ernst","year":"1999","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.410230431","article-title":"Cocanie and Tourette's syndrome","volume":"23","author":"Factor","year":"1988","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1006\/geno.1995.1265","article-title":"The dopamine transporter protein gene (SLC6A3): primary linkage mapping and linkage studies in Tourette syndrome","volume":"30","author":"Gelernter","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0925-4927(94)90014-0","article-title":"Dopamine receptor availability in Tourette's syndrome","volume":"55","author":"George","year":"1994","journal-title":"Psychiatry Research. Neuroimaging"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib17","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1212\/WNL.54.6.1310","article-title":"Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial","volume":"54","author":"Gilbert","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib18","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1212\/01.wnl.0000242733.18534.2c","article-title":"Altered mesolimbocortical and thalamic dopamine in Tourette syndrome","volume":"67","author":"Gilbert","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/1531-8257(199905)14:3<502::AID-MDS1020>3.0.CO;2-G","article-title":"Advantages of a modified scoring method for the Rush Video-Based Tic Rating Scale","volume":"14","author":"Goetz","year":"1999","journal-title":"Movement Disorders"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3928\/0090-4481-19880601-08","article-title":"The relationship between stimulant medication and tics","volume":"17","author":"Golden","year":"1988","journal-title":"Pediatric Annals"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0022-510X(86)90097-3","article-title":"Gilles de la Tourette's syndrome. A postmortem neuropathological and immunohistochemical study","volume":"75","author":"Haber","year":"1986","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1212\/WNL.51.4.1069","article-title":"Tourette's syndrome: [I-123]\u03b2-CIT SPECT correlates of vocal tic severity","volume":"51","author":"Heinz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000047962","article-title":"Downregulation of striatal dopamine D2 receptors in advanced Parkinson's disease contributes to the development of motor fluctuation","volume":"47","author":"Hwang","year":"2002","journal-title":"European Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib24","first-page":"207","article-title":"Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease","volume":"45","author":"Hwang","year":"2004","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib25","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1212\/WNL.45.6.1176","article-title":"Cerebral morphometric abnormalities in Tourette's syndrome: a quantitative MRI study of monozygotic twins","volume":"45","author":"Hyde","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.34.5.688","article-title":"Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome","volume":"34","author":"Jankovic","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib27","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1212\/WNL.28.10.1064","article-title":"Gilles de la Tourette's syndrome after long-term chlorpromazine therapy","volume":"28","author":"Klawans","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib28","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s00415-002-0746-9","article-title":"Elevated striatal dopamine transporter in a drug na\u00efve patient with Tourette syndrome and attention deficit\/hyperactivity disorder: positive effect of methylphenidate","volume":"249","author":"Krause","year":"2002","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib29","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/WNL.49.6.1699","article-title":"Coexistence of tics and parkinsonism: evidence for non-dopaminergic mechanisms in tic pathogenesis","volume":"49","author":"Kumar","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib30","first-page":"339","article-title":"A kit formulation for preparation of 123I-IBZM: a new CNS D2 dopamine receptor imaging agent","volume":"32","author":"Kung","year":"1991","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib31","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/BF01254479","article-title":"Imaging of dopamine transporters in humans with technetium-99\u00a0m TRODAT-1","volume":"23","author":"Kung","year":"1996","journal-title":"European Journal of Nuclear Medicine"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1176\/ajp.152.9.1359","article-title":"[123I]\u03b2-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder","volume":"152","author":"Malison","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM198608073150616","article-title":"Cocaine and Tourette's syndrome","volume":"315","author":"Mesulam","year":"1986","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.53.2.371","article-title":"Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome","volume":"53","author":"Meyer","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/PL00007806","article-title":"Dopamine transporter binding in Gilles de la Tourette syndrome","volume":"247","author":"M\u00fcller-Vahl","year":"2000","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0404.2000.101003165.x","article-title":"Dopamine D2 receptor imaging in Gilles de la Tourette syndrome","volume":"101","author":"M\u00fcller-Vahl","year":"2000","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2005.05.031","article-title":"Serotonin transporter binding in Tourette syndrome","volume":"385","author":"M\u00fcller-Vahl","year":"2005","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib38","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/01.WNL.0000086370.10186.7C","article-title":"Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome","volume":"61","author":"Pappert","year":"2003","journal-title":"Neurology"},{"issue":"Suppl. 9","key":"10.1016\/j.pscychresns.2007.04.006_bib39","first-page":"24","article-title":"Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome","volume":"57","author":"Peterson","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib40","first-page":"179","article-title":"Neuroimaging studies of Tourette syndrome: a decade of progress","volume":"85","author":"Peterson","year":"2001","journal-title":"Advances in Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib41","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/WNL.43.5.941","article-title":"Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images","volume":"43","author":"Peterson","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib42","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1212\/01.WNL.0000055434.39968.67","article-title":"A placebo-controlled trial of risperidone in Tourette syndrome","volume":"60","author":"Scahill","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.0001-690X.2004.00214.x","article-title":"Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT\/SPECT study","volume":"109","author":"Serra-Mestres","year":"2004","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archpsyc.1989.01810080052006","article-title":"Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome","volume":"46","author":"Shapiro","year":"1989","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ana.410120408","article-title":"Dopaminergic dysfunction in Tourette syndrome","volume":"12","author":"Singer","year":"1982","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/ana.410300408","article-title":"Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette syndrome","volume":"30","author":"Singer","year":"1991","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib47","first-page":"233","article-title":"Positron emission tomography evaluation of dopamine D2 receptors in adults with Tourette syndrome","volume":"58","author":"Singer","year":"1992","journal-title":"Advances in Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib48","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.43.5.950","article-title":"Volumetric MRI changes in basal ganglia of children with Tourette's syndrome","volume":"43","author":"Singer","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib49","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/appi.ajp.159.8.1329","article-title":"Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET","volume":"159","author":"Singer","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0924-977X(00)00134-6","article-title":"No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [123I]\u03b2-CIT SPECT study","volume":"11","author":"Stamenkovic","year":"2001","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib51","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archpsyc.1974.01760180095012","article-title":"Presynaptic catecholamine antagonists as treatment for Tourette syndrome: effects of alpha-methyl-para-tyrosine and tetrabenazine","volume":"31","author":"Sweet","year":"1974","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib52","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/jnnp.57.6.688","article-title":"PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome","volume":"57","author":"Turjanski","year":"1994","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib53","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.273.5279.1225","article-title":"Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding","volume":"273","author":"Wolf","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib54","first-page":"130P","article-title":"Dopamine transporter reuptake sites measured by [C11]WIN 35,428 PET imaging are elevated in Tourette syndrome patients (abstract)","volume":"35","author":"Wong","year":"1994","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.pscychresns.2007.04.006_bib55","first-page":"1243","article-title":"D2-like dopamine receptor density in Tourette syndrome measured by PET","volume":"38","author":"Wong","year":"1997","journal-title":"Journal of Nuclear Medicine"}],"container-title":["Psychiatry Research: Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492707000844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492707000844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T08:00:59Z","timestamp":1546329659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925492707000844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0925492707000844"],"URL":"https:\/\/doi.org\/10.1016\/j.pscychresns.2007.04.006","relation":{},"ISSN":["0925-4927"],"issn-type":[{"value":"0925-4927","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}